Anti-Amyloid Alzheimer's Drugs Show No Clinically Meaningful Benefit in Cochrane Review
A new Cochrane review found that drugs targeting amyloid beta proteins in the brain likely have no clinically meaningful positive effects while increasing the risk of brain bleeding and swelling.
·1 source
